How your skin's microbes shape immunity, inflammation, and chronic skin disease

How your skin's microbes shape immunity, inflammation, and chronic skin disease

From childhood through adulthood, bacteria and fungi on your skin help your immune system - but when these balance tips, chronic inflammation can follow. This new review shows how and why.

Published in a recent review in the JournalExperimental and molecular medicineThe researchers in South Korea studied the interactions between commensal skin microbiota and the epithelial and immune systems throughout the human lifespan and examined their influence on health and disease.

background

Have you ever wondered why your skin heals differently at different ages or why some people are more prone to conditions like eczema or acne? One clue lies in the microscopic inhabitants of your skin. Human skin is home to billions of microorganisms, including bacteria, fungi and viruses, which are not just passive passengers. These commensal microbes actively form immune responses and repair tissues. From childhood to adulthood, they train immune cells, protect against pathogens and maintain the integrity of the barrier function. However, imbalances in this ecosystem can drive inflammation and chronic skin diseases. Despite this knowledge, the molecular pathways and long-term consequences of these microbial interactions remain distinctive, requiring further research.

Skin: a habitat and an immune interface

Newborns with higher Staphylococcus hominis levels at 2 months of age have a 40% lower risk of atopic dermatitis at 1 age, indicating early colonization issues.

Skin is more than a protective shield – it is an ecosystem. Its surface consists of epidermis, dermis and subcutaneous tissue and provides niches for a variety of commensal microbiota. These microorganisms, includingStaphylococcus epidermidis(S. epidermidis),Cutibacterium acnes(C. acnes), investigated experimentallyLactobacillus rhamnosusGg, andMalasseziaFungi interact with skin cells and contribute to barrier integrity, hydration and immune modulation.

Like commensalsS. epidermidisSupport wound healing whileS. hominisinhibits the growth of pathogens such as:Staphylococcus aureus(S. aureus). Others likeC. acnesproduce propionic acid (a short-chain fatty acid), which strengthens the skin barrier by activating peroxisome proliferator-activated receptor alpha (PPARα) in keratinocytes. Meanwhile, microbial metabolites such as indole-3-aldehyde and quinolinic acid activate the aryl hydrocarbon receptor (AHR) pathway in keratinocytes, reducing inflammation and potentially alleviating diseases such as psoriasis. Additionally,MalasseziaIt has been shown to inhibitS. aureusFormation of biofilm that supports microbial balance on the skin surface.

Skin microbiota regulates both skin homeostasis and barrier function. They improve barrier function by activating the AHR pathway in keratinocytes. Furthermore, metabolites (IALD and quinolinic acid) from skin microbiota alleviate skin inflammation by activating AHR signaling in keratinocytes. This pathway inhibits TSLP and the NLRP3 inflammasome, thereby attenuating atopic dermatitis and psoriasis. COMPORSAL MICROBIOTA COMOLISION of skin wounds form Cxcl10 bacterial DNA complexes that activate plasmacytoid dendritic cells (PDCs) to produce type I interferons. These PDCs promote tissue repair through macrophage-mediated processes. COMMENSAL skin microbiota stimulates keratinocytes to generate stem cell factors (SCFs) that induce mast cell maturation. S. epidermidis strengthens the skin barrier, promotes tissue repair, maintains homeostasis, and induces tolerance to commensal microorganisms. This is achieved by producing ceramides and inducing label-specific T cells through interactions with DCs and Treg cells via peptide ligands and antigen recognition. Additionally, S. epidermidis can exacerbate skin inflammation through the expansion of γδ T cells. C. acnes also supports skin barrier function by producing triglycerides and similarly contributes to inflammation through γδ T cell expansion. Malassezia, a skin fungus, inhibits biofilm formation by S. aureus.

Early life and immune programming

Initial encounters with skin microbiota during infancy leave permanent marks. For example, exposure to riboflavin-producing bacteria such as:S. epidermidispromotes the development of mucosal associated invariant T (Mait) cells and regulatory T (Treg) cells, which are essential for immune tolerance. These effects persist into adulthood and shape the immune system's response to microbes and injury.

Studies in mice have shown that early exposure toS. aureusmay even protect against the development of atopic dermatitis later in life. Conversely, early exposure or disruption of the skin barrier during infancy can lead to increased inflammation and diseases such as psoriasis in adulthood. These early microbial encounters can lead to immunoimprinting through chromatin remodeling and gene accessibility changes, although the persistence of these effects requires further investigation.

Microbiota-immune cell interaction

Indole-3-aldehyde, a metabolite from skin bacteria like Lactobacillus, calms inflammation by directing immune cells toward tolerance rather than attack.

COMMENSAL microbes conduct constant cross-talk with skin-dwelling immune cells such as macrophages, dendritic cells (DCs), gamma-delta (γδ) T cells and innate lymphoid cells (ILCs). For example,S. epidermidisPeptides activate DCs, which then stain specific T cells for microbial tolerance. Similarly, skin macrophages regulate bacterial infections by controlling hyaluronic acid degradation, while DCs and keratinocytes recognize microbes via Toll-like receptors (TLRs) and trigger immune responses.

When this balance is disrupted, inflammation occurs.S. aureusFor example, α-toxin activates protease-activated receptor 1 (PAR1) in neurons, causing itching and damage. In some cases, the same microbes that promote healing can cause disease when they penetrate deeper or deeper layers of skin.

Skin disorders and microbial shifts

Butyrate from S. epidermidis increases antimicrobial peptide production in keratinocytes and acts like a natural antibiotic factory on your skin.

Conditions such as atopic dermatitis, psoriasis and acne are closely linked to microbial imbalance, called dysbiosis. In atopic dermatitis, reduced filaggrin (a protein crucial for barrier function) leads to overgrowth ofS. aureuswhich worsens inflammation by stimulating T helper 2 (Th2) cells through cytokines such as interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP).

Psoriasis, which affects 1–3% of the world's population, is driven by the interleukin-23-INTERLEUKIN-17 (IL-23-IL-17) axis. Mice without a microbiota have milder symptoms, indicating that certain bacteria worsen inflammation.Staphylococcus WarneriAndCandida albicansworsens lesions duringStaphylococcus CohniiAppears protective, likely through suppression of IL-17 signaling, a key driver of psoriatic inflammation.

Acne, often blamedC. acnesis more nuanced. While this bacteria is not necessarily more common in acne sufferers, its balance with other microbes such asS. epidermidisaffects inflammation. Acne severity correlates with reduced microbial diversity and increased abundance of Firmicutes and increasedEnterococcusSpecies. The review does not address fungal involvement in acne, and such associations remain unconfirmed.

Friend or foe? The commensal dilemma

What determines whether a microbe helps or harms? Under healthy conditions, commensals are tolerated. However, under immune suppression or skin barrier defects, even friendly microbes can become opportunistic pathogens. For example,S. epidermidiscan shift from symbiont to threat by producing lipases and proteases. Similar,MalasseziaAndC. albicanstypically harmless fungi, can cause illness if immunity falters.

The immune system distinguishes Freund from FOE through various cues, including microbial metabolites and virulence factors. For example,S. aureusα-toxin limits Treg formation, leading to immune activation instead of tolerance. While pattern recognition receptors such as TLRs are involved in microbial invention, the review does not detail specific early life discrimination mechanisms. Understanding this microbial switch could lead to better treatments for inflammatory diseases.

Why epigenetics is important

Skin microbes likeS. epidermidismay influence immune development by altering chromatin structure and increasing accessibility in key immune genes. Some bacteria produce SCFAs such as butyrate, which block histone deacetylases and reduce pathogen growth. Researchers are still studying how long-lasting these changes are and whether they shape immune memory.

These findings open new doors. Could spring interventions with probiotics prevent chronic skin diseases? Could microbiota-derived metabolites become next-generation therapies? Research into the epigenetic influence of the skin microbiome can help answer these questions.

Conclusions

In conclusion, this study demonstrates how immune development, barrier integrity, and disease susceptibility from early life to adulthood shape the commensal skin microbiota. These microbes are not passive passengers; They train immune cells, promote tissue repair and even regulate gene expression through epigenetic modifications. However, disorders due to genetic mutations, environmental factors or antimicrobial treatments can trigger inflammatory diseases such as atopic dermatitis, psoriasis and acne. Recognizing the bidirectional crosstalk between skin microbes and host systems highlights the need for personalized microbiome-derived therapies. Clarifying the long-term effects of microbial interactions on gene expression and immune memory could inform future approaches to treating chronic skin diseases. Harnessing this microbial influence offers promising avenues to better treat chronic skin conditions and overall skin health.

Sources: